|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1999-4-14
|
|
pubmed:abstractText |
Preoperative treatment with 600 U/kg of recombinant human erythropoietin (r-HuEPO) effectively increases erythropoiesis in cancer patients. The aim of this study was to evaluate the erythropoietic response after different doses of r-HuEPO in order to find the minimum effective dose.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0042-9007
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
76
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
38-42
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:9933852-Adenocarcinoma,
pubmed-meshheading:9933852-Aged,
pubmed-meshheading:9933852-Anemia,
pubmed-meshheading:9933852-Colorectal Neoplasms,
pubmed-meshheading:9933852-Dose-Response Relationship, Drug,
pubmed-meshheading:9933852-Erythropoiesis,
pubmed-meshheading:9933852-Erythropoietin,
pubmed-meshheading:9933852-Female,
pubmed-meshheading:9933852-Humans,
pubmed-meshheading:9933852-Male,
pubmed-meshheading:9933852-Middle Aged,
pubmed-meshheading:9933852-Pancreatic Neoplasms,
pubmed-meshheading:9933852-Preoperative Care,
pubmed-meshheading:9933852-Prospective Studies,
pubmed-meshheading:9933852-Recombinant Proteins,
pubmed-meshheading:9933852-Stomach Neoplasms
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Erythropoiesis after therapy with recombinant human erythropoietin: a dose-response study in anemic cancer surgery patients.
|
|
pubmed:affiliation |
Department of Surgery, Scientific Institute San Raffaele Hospital, University of Milan, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
